Kv1.3 potassium channel blockers (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKv1.3 potassium channel blockers (AstraZeneca)
Drug Alias NameM-376933M-377168
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressantsPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A